Clinical Trial Update: Safety and Efficacy of MEM 3454 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing MEM 3454 to placebo in mild-to-moderate Alzheimer's disease completed, evaluating safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• MEM 3454

Snippet

Sponsor: Memory Pharmaceuticals | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED